◀ Back to MAPK12
CHI3L1 — MAPK12
Text-mined interactions from Literome
Michelsen et al., Atherosclerosis 2010
(Carotid Artery Diseases...) :
Our main findings were : ( 1 ) serum YKL-40 levels were significantly elevated in patients with carotid atherosclerosis, with particularly high levels in those with symptomatic disease ; ( 2 ) patients with recent ischemic symptoms ( within 2 months ) had higher YKL-40 mRNA levels in carotid plaque than other patients ; ( 3 ) in vitro, the beta-adrenergic receptor agonist isoproterenol, toll-like receptor (TLR) 2 and TLR4 agonists, and in particular releasate from activated platelets significantly increased the expression of YKL-40 in THP-1 monocytes and ( 4 ) in vitro,
YKL-40 increased matrix metalloproteinase-9 expression and activity in THP-1 monocytes, involving activation of p38
mitogen activated protein kinase
Faibish et al., Mol Cancer Ther 2011
(Disease Progression...) :
mAY also abolished
YKL-40 induced activation of the membrane receptor VEGF receptor 2 ( Flk-1/KDR ) and intracellular signaling
mitogen activated protein ( MAP ) kinase extracellular signal regulated kinase ( Erk ) 1 and Erk 2
Shao et al., Frontiers in physiology 2013
:
In addition,
YKL-40 induces
FAK-MAPK signaling and up-regulates VEGF receptor 2 in endothelial cells ; but a neutralizing antibody ( mAY ) against YKL-40 inhibits its angiogenic activity